Skip to main content
Addgene

SKI complex loss renders 9p21.3-deleted or MSI-H cancers dependent on PELO.

Borck PC, Boyle I, Jankovic K, Bick N, Foster K, Lau AC, Parker-Burns LI, Lubicki DA, Li T, Borah AA, Lofaso NJ, Das Sharma S, Chan T, Kishen RV, Adeagbo A, Raghavan S, Aquilanti E, Prensner JR, Krill-Burger JM, Golub TR, Campbell CD, Dempster JM, Chan EM, Vazquez F
Nature. 2025 Feb 5. doi: 10.1038/s41586-024-08509-3. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
228932pXPR_023d sgCiPELO #1Expression of dCas9-KRAB and sgRNA targeting PELO
228934pXPR_023d sgCiPELO #8Expression of dCas9-KRAB and sgRNA targeting PELO
228935pRDA_174_neoRLentiviral expression of EnAsCas12a
228936pXPR_051_dCas9-KRAB-HAAll-in-one dCas9-KRAB-MeCP2 plasmid for cloning of custom sgRNA
228937pRDA_052_HygroRPlasmid for cloning of custom gRNA using EnAsCas12a
228938pLX313_PELO_WTConstitutive expression of wild-type human PELO
228940pXPR_051d_sgCiChr2-2Expression of a CRISPRi control sgRNA that cuts an intergenic region on chromosome 2
229017pXPR_BRD051d_sgCiPELO #1Expression of CRISPRi PELO sgRNA #1
229018pXPR_BRD051d_sgCiPELO #2Expression of CRISPRi PELO sgRNA #2
229020pRDA355_sgCiPELO #2Expression of a CRISPRi doxycycline inducible guide targeting PELO
229021pRDA355_sgCiCh2-2Expression of a CRISPRi doxycycline inducible control sgRNA that cuts an intergenic region on chromosome 2
229022pRDA355_sgCiPOLR2DExpression of a CRISPRi doxycycline inducible guide targeting POLR2D
229023pRDA052H_sgCh2Expression of a EnAsCas12a control guide that cuts an intergenic region on chromosome 2
229024pRDA052H_sgFOCAD #2Expression of a EnAsCas12a guide targeting FOCAD

Antibodies from Article